Outcomes Length of intervention in weeks (Median, (IQR)) · people with congenital heart disease.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term impact (< 12 months) child vegetable intake · children aged 5 years and under
1 finding from 1 review
Cost‐effectiveness ‐ not reported · children aged 5 years and under
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term impact (< 12 months) unintended adverse events · children aged 5 years and under
1 finding from 1 review
Short‐term impact (< 12 months) child fruit and vegetable intake · children aged 5 years and under
1 finding from 1 review
Cost‐effectiveness ‐ not reported · children aged 5 years and under
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term impact (< 12 months) unintended adverse events ‐ not reported · children aged 5 years and under
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term impact (< 12 months) child fruit and vegetable intake · children aged 5 years and under
1 finding from 1 review
Cost or cost effectiveness ‐ not reported · children aged 5 years and under
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Unintended adverse events ‐ not reported · children aged 5 years and under
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term impact (< 12 months) child fruit and vegetable intake · children aged 5 years and under
1 finding from 1 review
Cost‐effectiveness · children aged 5 years and under
1 finding from 1 review
Short‐term impact (< 12 months) unintended adverse events · children aged 5 years and under
1 finding from 1 review
Myocardial infarction · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (high dose) showed no clear difference in myocardial infarction compared with homocysteine‐lowering interventions (low dose) (moderate certainty).
1 finding from 1 review
Stroke · people with or without existing cardiovascular disease, men and women
It is very uncertain whether homocysteine‐lowering interventions (high dose) changes stroke compared with homocysteine‐lowering interventions (low dose) (very low certainty).
1 finding from 1 review
Death by any cause · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (high dose) showed no clear difference in death by any cause compared with homocysteine‐lowering interventions (low dose) (moderate certainty).
1 finding from 1 review
Cancer · people with or without existing cardiovascular disease, men and women
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
CVD events ‐ not reported · people at high risk of CVD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
LDL cholesterol (mmol/L), change from baseline · people at high risk of CVD
1 finding from 1 review
HDL cholesterol (mmol/L), change from baseline · people at high risk of CVD
1 finding from 1 review